XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
 9 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Repurchase Agreements
The following table summarizes total shares repurchased during the three and nine months ended December 31, 2023 and 2022:
November 2020 ProgramAugust 2022 ProgramTotal
(In millions)SharesAmountShares
Amount(a)
SharesAmount
Three months ended December 31, 2023
— $— 2.5 $325 2.5 $325 
Nine months ended December 31, 2023
— $— 7.6 $975 7.6 $975 
Three months ended December 31, 2022
— $5 2.6 $320 2.6 $325 
Nine months ended December 31, 2022
5.1$650 2.6 $320 7.7 $970 
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the nine months ended December 31, 2023:
Options
(in thousands)		Weighted-
Average
Exercise Prices		Weighted-
Average
Remaining
Contractual
Term  (in years)		Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2023
121 $40.43 
Granted2 128.90 
Exercised(90)39.28 
Outstanding as of December 31, 2023
33 $50.31 2.62$3 
Vested and expected to vest33 $50.31 2.62$3 
Exercisable as of December 31, 2023
33 $50.31 2.62$3 
The following table summarizes our restricted stock units activity for the nine months ended December 31, 2023:
Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 20237,502 $128.54 
Granted4,521 128.76 
Vested(3,668)130.08 
Forfeited or cancelled(664)129.56 
Outstanding as of December 31, 20237,691 $127.85 
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2023:
Performance-
Based Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2023557 $130.03 
Granted682 128.66 
Vested(73)127.98 
Forfeited or cancelled(330)128.74 
Outstanding as of December 31, 2023836 $129.60 
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2023:
Market-Based
Restricted  Stock
Units
(in thousands)		Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2023822 $149.98 
Granted143 152.92 
Vested(50)125.62 
Forfeited or cancelled(561)141.20 
Outstanding as of December 31, 2023354 $168.53 
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
 Three Months Ended
December 31,		Nine Months Ended
December 31,
 2023202220232022
Cost of revenue$2 $2 $6 $5 
Research and development108 95 314 271 
Marketing and sales14 15 38 44 
General and administrative27 29 78 86 
Stock-based compensation expense$151 $141 $436 $406